NASH肝発癌におけるソラフェニブ/アンジオテンシンII受容体阻害薬併用療法と血清可溶性VEGF Receptor2の意義

2013 
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []